Specifically, the increase in glutamatergic terminals together with hippocampal hyperactivity were previously shown in humans with mild AD [88], and increased excitability of pyramidal neurons at early stages of AD was reported in mice [77, 89], where hippocampal VGLUT1 expression was upregulated [53]. The gene discussed is SLC17A7; the disease is Alzheimer disease.